The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A drug-drug interaction study on the combination of cabazitaxel with enzalutamide in patients with metastatic castration-resistant prostate cancer.
 
Bodine P.S. Belderbos
Travel, Accommodations, Expenses - Astellas Oncology
 
Sander Bins
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma
Travel, Accommodations, Expenses - Roche
 
Roelof W.F. van Leeuwen
Honoraria - Astellas Oncology
Travel, Accommodations, Expenses - Astellas Oncology; Pfizer; Roche
 
Esther Oomen De Hoop
No Relationships to Disclose
 
Nelly van der Meer
No Relationships to Disclose
 
Peter de Bruijn
No Relationships to Disclose
 
Paul Hamberg
Speakers' Bureau - Astellas Oncology; Sanofi
 
Esther N.M. Overkleeft
No Relationships to Disclose
 
Wendy M. van der Deure
No Relationships to Disclose
 
Martijn P. Lolkema
Research Funding - Astellas Oncology
 
Ronald De Wit
Honoraria - Lilly; Merck Sharp & Dohme; Roche/Genentech; Sanofi
Consulting or Advisory Role - Lilly; Merck Sharp & Dohme; Roche/Genentech; Sanofi
Research Funding - Sanofi (Inst)
 
Ron H.J. Mathijssen
Consulting or Advisory Role - Astellas Oncology
Research Funding - Astellas Oncology; Bayer; Roche; Sanofi
Travel, Accommodations, Expenses - Pfizer; Roche